Dextrose and Sodium Chloride (Hospira, Inc.)
Welcome to the PulseAid listing for the Dextrose and Sodium Chloride drug offered from Hospira, Inc.. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | DEXTROSE MONOHYDRATE and SODIUM CHLORIDE |
SUBSTANCE NAME: | DEXTROSE MONOHYDRATE; SODIUM CHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-06-06 |
END MARKETING DATE: | 0000-00-00 |
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Dextrose and Sodium Chloride from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5; .225(g/100mL; g/100mL) |
START MARKETING DATE: | 2005-06-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-7924_8f538220-c2e5-43fb-96fc-a1747de11978 |
PRODUCT NDC: | 0409-7924 |
APPLICATION NUMBER: | NDA017606 |
Other DEXTROSE MONOHYDRATE; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers: